(Q36648740)

English

Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2.

scientific article published on January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2. (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

F De Paola

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

R Ridolfi

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Riccobon

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

E Flamini

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

F Barzanti

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A M Granato

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

G L Mordenti

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

L Medri

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

P Vitali

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

D Amadori

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

88

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

320-326

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

30 September 2017

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

30 September 2017

Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

30 September 2017

Signaling defects in T lymphocytes of patients with malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

30 September 2017

Developing recombinant and synthetic vaccines for the treatment of melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

30 September 2017

Human melanoma cells do not express Fas (Apo-1/CD95) ligand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

30 September 2017

Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

30 September 2017

Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

30 September 2017

Preventing abnormalities in signal transduction of T cells in cancer: the promise of cytokine gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

30 September 2017

Immunosuppressive factors in human cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

30 September 2017

T cell immune response to cancer in humans and its relevance for immunodiagnosis and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

30 September 2017

Tumor-infiltrating lymphocytes as antitumor effector cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

30 September 2017

Prognostic value of biomarkers in malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

28 June 2018

Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

28 June 2018

Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

20 September 2018

Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

20 September 2018

The role of Fas/FasL in immunosuppression induced by human tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

20 September 2018

Tumor-bearing animals contain suppressed antitumor effectors the function of which can be unmasked by IL-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377057

20 September 2018

Immune privilege or inflammation? Insights into the Fas ligand enigma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD43 monoclonal antibodies recognize the large sialoglycoprotein of human leukocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The decreased expression of CD3 ζ chains in cancer patients is not reversed BY IL-2 Administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-2 expression in malignant melanoma and its prognostic significance

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of apoptosis regulators in cutaneous malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic relevance of altered Fas (CD95)-system in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12610520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fas ligand and immune evasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600679

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BJC.6600679

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36648740&oldid=2199139034"